# CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY

> **NCT04673240** · — · UNKNOWN · sponsor: **Università degli Studi del Piemonte Orientale Amedeo Avogadro** · enrollment: 70 (estimated)

## Conditions studied

- Spasticity
- Brain Injuries
- Spinal Cord Injuries
- Multiple Sclerosis

## Interventions

- **DRUG:** Botulinum toxin type A injection

## Key facts

- **NCT ID:** NCT04673240
- **Lead sponsor:** Università degli Studi del Piemonte Orientale Amedeo Avogadro
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-29
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04673240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04673240, "CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT04673240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*